Skin study findings may help to explain why African ancestry is associated with a lower risk of severe dengue.

INmune Bio Inc. (NASDAQ: INMB) (the 'Company”), a clinical-stage inflammation and immunology company, today announced that it ...

The new study looks at how consuming vitamin B-12 led to a cascade of signals originating in the brain and triggering actions ...

Experts in the molecular genetics of stem cells and medicinal chemistry respectively, the two scientists at UdeM's Institute ...

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site ...

Northwestern Medicine investigators have identified a surprising culprit in the progression of inflammatory bowel disease: a ...

San Diego-based Capstan is developing a potential first-in-class therapy to treat certain autoimmune disease by changing ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 ...

AbbVie (ABBV) on Monday announced that it has entered into a definitive agreement to acquire privately held clinical-stage biotechnology company Capstan Therapeutics, Inc., in a bid to boost its ...

In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing ...